| Authors: |
Dabritz HA; Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, Richmond, CA., Panditrao MV; Research and Evaluation Branch, Office of Health Equity, California Department of Public Health, Richmond, CA., Pandey S; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA., Dover N; Microbial Diseases Laboratory Branch, Infectious Diseases Laboratories Division, California Department of Public Health, Richmond, CA., Barash JR; Microbial Diseases Laboratory Branch, Infectious Diseases Laboratories Division, California Department of Public Health, Richmond, CA., Khouri JM; Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, Richmond, CA., Read JS; Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, Richmond, CA. |